Skip to content
healthcare.dev
Get a free key

CABINET Allergy Relief

NDC 68210-0119, Cetirizine Hydrochloride, tablet, film coated, from Spirit Pharmaceutical LLC.

Product NDC
68210-0119
Status
Listed
Labeler
Spirit Pharmaceutical LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209274
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68210-0119 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
68210-0119-068210011900100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68210-0119-0)
68210-0119-168210011901300 TABLET, FILM COATED in 1 BOTTLE (68210-0119-1)
68210-0119-3682100119031 BOTTLE, PLASTIC in 1 CARTON (68210-0119-3) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68210-0119 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68210-0119 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68210-0119. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.